Accendra Health, Inc. (ACH)
Healthcare · NYQ
Fundamentals
Valuation and ratings
Accendra Health, Inc. trades at USD3.14. We do not hold enough of the inputs to run a discounted cash flow on this company, so we publish no fair value for it rather than a number we would not defend.
Our moat model scores it 23 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
ACH dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2021 | USD0.012 | 4 |
| 2020 | USD0.012 | 4 |
| 2019 | USD0.012 | 4 |
| 2018 | USD0.855 | 4 |
| 2017 | USD1.03 | 4 |
| 2016 | USD1.02 | 4 |
| 2015 | USD1.01 | 4 |
| 2014 | USD1.00 | 4 |
| 2013 | USD0.960 | 4 |
| 2012 | USD0.880 | 4 |
| 2011 | USD0.800 | 4 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
ACH earnings and analyst estimates
Recommendation mix, 6 analyst ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
ACH passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
10 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- D. E. Shaw, D. E. Shaw & Co., Inc.$7.55M · 0.0% of book
- Marshall Wace, MARSHALL WACE, LLP$4.02M · 0.0% of book
- Two Sigma, TWO SIGMA INVESTMENTS, LP$2.74M · 0.0% of book
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$1.67M · 0.0% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$1.08M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Common questions
Which funds own ACH?
10 of the institutions we track reported a position in ACH in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
When does ACH report earnings next?
Accendra Health, Inc. is scheduled to report on 10 Aug 2026. Companies move earnings dates, so read it as scheduled rather than certain.
The full research page for ACH, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.